Facilitated By

San Antonio Medical Foundation

News

  • After building pipelines from GlaxoSmithKline to Flagship, Paul Peter Tak takes the helm at an ...

    Then he was asked to hop on Zoom to talk about Candel — a biotech he's never heard of but works in oncolytic viruses, an instantly recognizable ...

  • The Latest: Tokyo's daily infections top 600 for first time

    ... Serum Institute of India, which has been licensed to manufacture the AstraZeneca vaccine, Pfizer Inc., and Indian manufacturer Bharat Biotech. ___.

  • Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at ...

    ... from the Phase III ExteNET trial were presented at the 2020 Virtual San Antonio Breast Cancer Symposium (SABCS) that is currently taking place.

  • Immutep Reports Statistically Significant Survival Benefit for Key Patient Groups in the Ongoing ...

    ... IMMP) a biotechnology company developing novel immunotherapy treatments for cancer ... These data were selected to be presented in a spotlight presentation at the San Antonio Breast Cancer Symposium 2020, which is being ...

  • Puma Biotechnology Presents Updated Results from the Phase II SUMMIT Trial of Neratinib for ...

    ... trial of neratinib at the 2020 Virtual San Antonio Breast Cancer Symposium ... NERLYNX is a registered trademark of Puma Biotechnology, Inc.